PURDUE PHARMA v. EIGHTH JUD. DIST. COURT

PURDUE PHARMA L.P.; Purdue Pharma, Inc.; The Purdue Frederick Company Inc.; Purdue Pharmaceuticals L.P.; Teva Pharmaceuticals USA, Inc.; Cephalon, Inc.; Johnson & Johnson; Janssen Pharmaceuticals, Inc.; Ortho-McNeil-Janssen Pharmaceuticals, Inc., n/k/a Janssen Pharmaceuticals, Inc.; Janssen Pharmaceutica, Inc., n/k/a Janssen Pharmaceuticals, Inc.; Abbvie Inc.; Abbvie US LLC; Endo Pharmaceuticals Inc.; Endo Health Solutions, Inc.; Allergan, Inc.; Allergan USA, Inc.; Allergan Finance, LLC, f/k/a Actavis, Inc., f/k/a Watson Pharmaceuticals, Inc.; Watson Laboratories, Inc.; Actavis LLC; Actavis Pharma, Inc., f/k/a Watson Pharma, Inc.; Insys Therapeutics, Inc.; and Mallinckrodt LLC, Petitioners, v. The EIGHTH JUDICIAL DISTRICT COURT of the State of Nevada, IN AND FOR the COUNTY OF CLARK; and the Honorable Timothy C. Williams, District Judge, Respondents, and Clark County, Real Party in Interest.